亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

DBSMatchMaker: Connecting Clinicians Globally for Deep Brain Stimulation in Rare Diseases

脑深部刺激 神经科学 刺激 医学 脑刺激 心理学 病理 帕金森病 疾病
作者
Umar Zubair,Habibah A.P. Agianda,Kathryn Yang,Amy Tam,Junkang Rong,Carolina Gorodetsky,Shekeeb S. Mohammad,Juan Darío Ortigoza‐Escobar,Darius Ebrahimi‐Fakhari
出处
期刊:Movement Disorders [Wiley]
被引量:1
标识
DOI:10.1002/mds.30131
摘要

The field of genetic movement disorders is rapidly evolving. Most manifest during childhood as hyperkinetic conditions with substantial morbidity. Although all are rare diseases, many emerging entities are ultrarare, affecting fewer than 100 individuals worldwide. Deep brain stimulation (DBS) is an effective treatment for dystonia and other hyperkinetic disorders, and evidence continues to emerge supporting its use across an expanding range of monogenic conditions, sometimes with remarkable benefit (examples published in 20241-6). This underscores the importance of considering DBS early in such cases. Certain conditions, such as TOR1A-related dystonia, already have well-established indications for DBS. Meanwhile, a growing list of monogenic diseases (ACTB, ADCY5, EIF2AK2, GNAL, GNAO1, GNB1, KMT2B, PANK2, SGCE, TAF1, THAP1, UBA5, VPS16) should be prioritized for DBS evaluation. Despite this, many rare movement disorders remain poorly understood with respect to their response to DBS and optimal patient selection. Even highly specialized centers often have limited experience, and decision-making is frequently guided by anecdotal observations only. Informal collaborations among specialists, as well as groups like the DBS Think Tank, the MDS Pediatric Movement Disorders Special Interest Group, and the ERN-RND Dystonia Working Group, offer valuable forums for knowledge sharing. However, these platforms may not be readily accessible to everyone and lack a formal structure. In the field of genetics, a similar challenge in the discovery of novel disease-associated genes has been addressed by GeneMatcher, with tremendous success.7 Drawing inspiration from this model and incorporating feedback from DBS communities across different health-care settings, we developed DBSMatchMaker (https://www.dbsmatchmaker.com/) (Fig. 1). DBSMatchMaker connects clinicians worldwide enabling them to evaluate the appropriateness of DBS for patients with monogenic movement disorders of all ages. The workflow is straightforward and requires minimal data: Information about the genetic condition, the anticipated or implanted DBS target, and consent to share the email contact for the purpose of matching (Fig. 1). Optionally, response to DBS is recorded using a simple three-point scale. Upon submission, the system automatically queries the database, and staff verify contributors' institutional affiliations to ensure entries are unique and free of duplication. If a match is found, the submitters are notified via email. If no match is identified, the gene of interest remains in the system for future queries. DBSMatchMaker adheres to strict safety and privacy protocols: The database is not searchable, and no identifiable data are collected. Genes entered in the database are displayed on the homepage along with submitter-rated treatment responses (Fig. 1). We hope that DBSMatchMaker's user-friendly interface, minimal mandatory data requirements, and direct relevance to patient care will reduce barriers and encourage participation from centers worldwide. In summary, by fostering global collaboration, DBSMatchMaker aims to enhance patient selection, counseling, treatment strategies, research, and overall outcomes for individuals with rare genetic movement disorders. We are excited to see this platform grow with each submission by the community, making it increasingly valuable for future users. D.E.-F. conceptualized and designed the DBSMatchMaker. K.Y., C.G., S.S.M., and J.D.O.-E. provided critical feedback and refined the platform. U.Z. and H.A. built the DBSMatchMaker website and database. K.Y., A.T. and J.R. organized the study protocol. D.E.-F. drafted the original manuscript, with contributions from other authors. All authors contributed to the final draft of the manuscript. We thank the members of the DBS Think Tank for their valuable feedback on the design of DBSMatchMaker. The Boston Children's Hospital Movement Disorders Program team extends its gratitude to the patients and families who support research on pediatric movement disorders. We also sincerely thank all contributors to DBSMatchMaker. Umar Zubair: employment, Boston Children's Hospital. Habibah A.P. Agianda: employment, Boston Children's Hospital. Kathryn Yang: employment, Boston Children's Hospital. Amy Tam: employment, Boston Children's Hospital. Joshua Rong: none. Carolina Gorodetsky: consultancies, Medtronic Inc.; advisory boards, Medtronic Inc.; employment, SickKids Hospital, University of Toronto, Canada; honoraria, Medtronic Inc. and Ipsen. Shekeeb S. Mohammad: employment, the University of Sydney, NSW Health, Australia; grants, CI-MRF2031200. Juan Darío Ortigoza-Escobar: advisory boards, scientific advisory board (unpaid): Asociación GNAO1 España; editorial board (unpaid): Pediatric Neurology; employment, Hospital Sant Joan de Deu, Barcelona; grants, Famiglie GNAO1 Research Grant and Torrons Vicens-Rac1 2024 Grant. Darius Ebrahimi-Fakhari: consultancies, Guidepoint LLC, Fondazione Telethon, German Center for Neurodegenerative Diseases, and the University of Texas Southwestern; advisory boards, scientific advisory board (unpaid): CureAP4 Foundation, the Maddie Foundation, SPG69/Warburg Micro Research Foundation, the Lilly and Blair Foundation, the Maurya Koduri Foundation, and Genetic Cures for Kids Inc.; employment, Boston Children's Hospital; honoraria, speaker honoraria from the Movement Disorders Society; royalties, Cambridge University Press; patents, PCT/US2024/029856; grants, NIH/NINDS, CureAP4 Foundation, Spastic Paraplegia Foundation, New England Epilepsy Foundation, BCH Office of Faculty Development, BCH Translational Research Program, BCH Technology, and Innovation Development Office. The data that support the findings of this study are available from the corresponding author upon reasonable request.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
上官若男的应助被红墨采纳,获得10
1秒前
李lichunn完成签到 ,获得积分10
4秒前
留胡子的鸿涛完成签到,获得积分10
8秒前
11秒前
null的应助被温暖砖头采纳,获得10
13秒前
邋遢大王完成签到,获得积分10
16秒前
糊涂的大碗完成签到 ,获得积分10
17秒前
liu完成签到 ,获得积分10
17秒前
23秒前
7788发布了新的文献求助10
25秒前
nader完成签到,获得积分10
26秒前
shamo发布了新的文献求助10
27秒前
大模型的应助被yehata采纳,获得30
27秒前
zkkz完成签到,获得积分10
29秒前
30秒前
耍酷的手套完成签到,获得积分10
32秒前
Zephyr完成签到 ,获得积分10
35秒前
独特鸵鸟的应助被温暖砖头采纳,获得10
36秒前
111完成签到,获得积分10
38秒前
38秒前
40秒前
lin完成签到,获得积分10
41秒前
42秒前
He08发布了新的文献求助10
44秒前
45秒前
瘦瘦的百褶裙完成签到 ,获得积分10
46秒前
光亮豌豆完成签到,获得积分10
47秒前
jinjinjin完成签到 ,获得积分10
49秒前
NexusExplorer的应助被刻苦灯泡采纳,获得10
52秒前
搞怪不言完成签到,获得积分10
52秒前
55秒前
7788完成签到,获得积分10
58秒前
2936276825完成签到,获得积分10
58秒前
2936276825发布了新的文献求助10
1分钟前
JamesPei的应助被高挑的橘子采纳,获得10
1分钟前
1分钟前
GingerF举报xiaowu的求助涉嫌违规
1分钟前
John发布了新的文献求助10
1分钟前
雪满头的应助被温暖砖头采纳,获得10
1分钟前
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8194962
求助须知:如何正确求助?哪些是违规求助? 9580711
关于积分的说明 21872442
捐赠科研通 7794663
什么是DOI,文献DOI怎么找? 3437819
关于科研通互助平台的介绍 2561143
邀请新用户注册赠送积分活动 2484511